Alexandria Real Estate Equities, Inc.'s Consequential Efforts to Address the Mission-Critical Need for Multifaceted Solutions to the Nation's Complex Mental Health Crisis
Rhea-AI Summary
Alexandria Real Estate Equities (NYSE: ARE) is intensifying its efforts to address the nation's mental health crisis through a multipronged approach. The company is leading a public-private partnership with the Foundation for the National Institutes of Health (FNIH) to develop biomarkers for depression treatment outcomes. Recent progress includes the FDA approval of Karuna Therapeutics' schizophrenia therapy and Intra-Cellular Therapies' potential new depression treatment.
Studies predict that by 2030, the global economic burden of mental health disorders will exceed that of cancer, diabetes, and respiratory diseases combined. ARE's initiatives include investing in innovative companies, advancing partnerships for biomarker development, influencing policy, and supporting organizations like the Navy SEAL Foundation, whose Warrior Fitness Program West Coast facility has helped over 200 active-duty warriors and veterans since late 2023.
Positive
- Partnership with FNIH to develop depression biomarkers for precision psychiatry
- Investment portfolio includes successful companies like Karuna Therapeutics (acquired by Bristol Myers Squibb)
- Contribution to Navy SEAL Foundation's Warrior Fitness Program, supporting over 200 veterans
- Strategic position in advancing mental health solutions through real estate and investments
Negative
- Growing global economic burden of mental health disorders expected to surpass cancer, diabetes, and respiratory diseases by 2030
News Market Reaction
On the day this news was published, ARE gained 3.73%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
"We are immensely proud of the positive impact and potential of our ongoing endeavors to address our country's staggering mental health crisis. As part of our latest effort, we continue to spearhead the development of a public-private partnership with the Foundation for the National Institutes of Health (FNIH) and leading-edge medicine companies, with the goal of transforming how depression is understood, diagnosed and treated — essentially, laying the groundwork for a new era of precision psychiatry," said Joel S. Marcus, executive chairman and founder of Alexandria Real Estate Equities, Inc. and Alexandria Venture Investments. "In observance of Mental Health Awareness Month this May, we call for a national public health agenda that prioritizes and spurs innovation in our great country. And we urge continued investment in neuropsychiatric research by the NIH and a well-resourced FDA with efficient and streamlined approval processes for critical diagnostics and therapeutics."
With studies predicting that by 2030 the global economic burden of mental health disorders will surpass that of cancer, diabetes and respiratory diseases, progress in advancing novel medicines for neuropsychiatry is seeing a renaissance. Recent advancements include a first-in-class FDA-approved schizophrenia therapy developed by Karuna Therapeutics, a former Alexandria venture investment company and a recent acquisition by longtime Alexandria tenant Bristol Myers Squibb. Also, in February, the FDA accepted a supplemental new drug application for an adjunctive treatment for adults with major depressive disorder submitted by Alexandria tenant and former investment company Intra-Cellular Therapies, now part of Johnson & Johnson. If approved, this treatment has potential to become a new standard of care for most common depressive disorders.
The mission-critical FNIH public-private partnership aims to develop data-driven measures to identify patient populations that are most likely to meaningfully respond to innovative new treatments for depression. Recognizing that depression is not a single disease, but a complex disorder with a wide range of symptoms, severities and treatment responses, this program takes a precision psychiatry approach and leverages cross-sector expertise and advanced analytics to pave the way for more personalized, effective care tailored to a patient's unique needs.
For more than 15 years, Alexandria has also been partnering with the Navy SEAL Foundation to support its vital mission to provide the nation's elite warriors with physical and mental health resources. Most recently, Alexandria played an instrumental role in establishing and launching the foundation's Warrior Fitness Program West Coast facility in
About Alexandria Real Estate Equities, Inc.
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500® company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator and developer of collaborative Megacampus™ ecosystems in AAA life science innovation cluster locations, including
Forward-Looking Statements
This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, without limitation, statements regarding the impact of Alexandria's corporate responsibility and thought leadership initiatives, practices, investments and progress, the likelihood of continued support, investment and partnership by Alexandria and the potential impacts of such activities on Alexandria's business and tenants, the companies and non-profit organizations in which Alexandria invests or with which Alexandria has strategic relationships, medicines for mental health disorders and the country's mental health crises. These forward-looking statements are based on Alexandria's present intent, beliefs or expectations, but forward-looking statements are not guaranteed to occur and may not occur. Actual results may differ materially from those contained in or implied by Alexandria's forward-looking statements as a result of a variety of factors, including, without limitation, the risks and uncertainties detailed in its filings with the Securities and Exchange Commission. All forward-looking statements are made as of the date of this press release, and Alexandria assumes no obligation to update this information. For more discussion relating to risks and uncertainties that could cause actual results to differ materially from those anticipated in Alexandria's forward-looking statements, and risks and uncertainties to Alexandria's business in general, please refer to Alexandria's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and any subsequently filed quarterly reports on Form 10-Q.
CONTACT: Sara Kabakoff, Senior Vice President – Chief Content Officer, (626) 788-5578, skabakoff@are.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/alexandria-real-estate-equities-incs-consequential-efforts-to-address-the-mission-critical-need-for-multifaceted-solutions-to-the-nations-complex-mental-health-crisis-302464589.html
SOURCE Alexandria Real Estate Equities, Inc.
FAQ
What is Alexandria Real Estate Equities (ARE) doing to address mental health crisis?
How many veterans has ARE's Navy SEAL Foundation Warrior Fitness Program helped?
What is the expected economic impact of mental health disorders by 2030?
What recent mental health treatment developments are connected to ARE?
What is ARE's partnership with FNIH focused on?
